summit study tirzepatide hfpef trial In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in trial https://t.co/8ZHm4gySiL Bridging the gap between GLP1-receptor

Long-term tirzepatide cardiovascular data is still being collected

This new terminology more accurately reflectsthe strong association between the disease and metabolic abnormalities

Smoking decreases the effectiveness of glutathione, making it harder for your body to combat oxidative stress

Over time, these small shifts in appetite and glycemia can produce modest reductions in body weight

For the past 25 years, Arthur M

By maintaining redox balance, glutathione can reduce inappropriate immune signaling and downstream mediator release [28] Forman et al., Glutathione: Overview of Its Protective Roles, Measurement, and Biosynthesis, Molecular Aspects of Medicine , Many individuals with MCAS also struggle with detoxification issues due to genetic variations or chronic inflammation